166 related articles for article (PubMed ID: 34988844)
1. Molecular Docking of Phytochemicals Targeting GFRs as Therapeutic Sites for Cancer: an In Silico Study.
Mendie LE; Hemalatha S
Appl Biochem Biotechnol; 2022 Jan; 194(1):215-231. PubMed ID: 34988844
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer.
Stany B; Mishra S; Rao KVB
Med Oncol; 2024 May; 41(6):156. PubMed ID: 38750377
[TBL] [Abstract][Full Text] [Related]
3. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
4. Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate Cancer.
Singh AN; Baruah MM; Sharma N
Sci Rep; 2017 May; 7(1):1955. PubMed ID: 28512306
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer.
Purawarga Matada GS; Dhiwar PS; Abbas N; Singh E; Ghara A; Das A; Bhargava SV
J Biomol Struct Dyn; 2022 Aug; 40(13):6183-6192. PubMed ID: 33525984
[TBL] [Abstract][Full Text] [Related]
6. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
Bultum LE; Tolossa GB; Lee D
PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
[TBL] [Abstract][Full Text] [Related]
7. In silico-based identification of phytochemicals as novel human phosphoglycerate mutase 1 (PGAM1) inhibitors for cancer therapy.
Kanwal N; Rasul A; Shah MA; Jabeen F; Sultana T
Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):665-670. PubMed ID: 34275800
[TBL] [Abstract][Full Text] [Related]
8. Computational Analysis of
Sangeet S; Khan A; Mahanta S; Roy N; Das SK; Mohanta YK; Saravanan M; Tag H; Hui PK
Curr Comput Aided Drug Des; 2023; 19(1):24-36. PubMed ID: 36221888
[TBL] [Abstract][Full Text] [Related]
9. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
[TBL] [Abstract][Full Text] [Related]
10. Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9.
Mustafa G; Younas S; Mahrosh HS; Albeshr MF; Bhat EA
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110817
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein.
Ahammad F; Alam R; Mahmud R; Akhter S; Talukder EK; Tonmoy AM; Fahim S; Al-Ghamdi K; Samad A; Qadri I
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834183
[TBL] [Abstract][Full Text] [Related]
12. Structure Based Drug Design and Molecular Docking Studies of Anticancer Molecules Paclitaxel, Etoposide and Topotecan using Novel Ligands.
Yadav M; Dhagat S; Eswari JS
Curr Drug Discov Technol; 2020; 17(2):183-190. PubMed ID: 30848204
[TBL] [Abstract][Full Text] [Related]
13. Screening of phytochemicals against protease activated receptor 1 (PAR1), a promising target for cancer.
Kakarala KK; Jamil K
J Recept Signal Transduct Res; 2015 Feb; 35(1):26-45. PubMed ID: 25007158
[TBL] [Abstract][Full Text] [Related]
14. Design of Potential IKK-β Inhibitors using Molecular Docking and Molecular Dynamics Techniques for their Anti-cancer Potential.
Singh SP; Hussain I; Konwar BK; Deka RC; Singh CB
Curr Comput Aided Drug Des; 2021; 17(1):83-94. PubMed ID: 31899679
[TBL] [Abstract][Full Text] [Related]
15. Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies.
Rampogu S; Parate S; Parameswaran S; Park C; Baek A; Son M; Park Y; Park SJ; Lee KW
Comput Biol Chem; 2019 Dec; 83():107113. PubMed ID: 31493740
[TBL] [Abstract][Full Text] [Related]
16. In silico molecular docking and in vitro antimicrobial efficacy of phytochemicals against multi-drug-resistant enteroaggregative Escherichia coli and non-typhoidal Salmonella spp.
Abishad P; Niveditha P; Unni V; Vergis J; Kurkure NV; Chaudhari S; Rawool DB; Barbuddhe SB
Gut Pathog; 2021 Jul; 13(1):46. PubMed ID: 34273998
[TBL] [Abstract][Full Text] [Related]
17. Exploration and evaluation of bioactive phytocompounds against BRCA proteins by
Prabhavathi H; Dasegowda KR; Renukananda KH; Lingaraju K; Naika HR
J Biomol Struct Dyn; 2021 Sep; 39(15):5471-5485. PubMed ID: 32643536
[TBL] [Abstract][Full Text] [Related]
18. In silico molecular docking and physicochemical property studies on effective phytochemicals targeting GPR116 for breast cancer treatment.
Muthiah I; Rajendran K; Dhanaraj P
Mol Cell Biochem; 2021 Feb; 476(2):883-896. PubMed ID: 33106912
[TBL] [Abstract][Full Text] [Related]
19. Analysis of plant-derived phytochemicals as anti-cancer agents targeting cyclin dependent kinase-2, human topoisomerase IIa and vascular endothelial growth factor receptor-2.
Sarkar B; Ullah MA; Islam SS; Rahman MH; Araf Y
J Recept Signal Transduct Res; 2021 Jun; 41(3):217-233. PubMed ID: 32787531
[TBL] [Abstract][Full Text] [Related]
20. Computational aided mechanistic understanding of Camellia sinensis bioactive compounds against co-chaperone p23 as potential anticancer agent.
Bharadwaj S; Lee KE; Dwivedi VD; Yadava U; Kang SG
J Cell Biochem; 2019 Nov; 120(11):19064-19075. PubMed ID: 31257629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
